FASLODEX (AstraZeneca Pharmaceuticals LP)
Welcome to the PulseAid listing for the FASLODEX drug offered from AstraZeneca Pharmaceuticals LP. This Estrogen Receptor Antagonist [EPC],Estrogen Receptor Antagonists [MoA],Selective Estrogen Receptor Modulators [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | AstraZeneca Pharmaceuticals LP |
| NON-PROPRIETARY NAME: | Fulvestrant |
| SUBSTANCE NAME: | FULVESTRANT |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Estrogen Receptor Antagonist [EPC],Estrogen Receptor Antagonists [MoA],Selective Estrogen Receptor Modulators [MoA] |
| ROUTE: | INTRAMUSCULAR |
| DOSAGE FORM: | INJECTION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2010-11-01 |
| END MARKETING DATE: | 0000-00-00 |
FASLODEX HUMAN PRESCRIPTION DRUG Details:
| Item Description | FASLODEX from AstraZeneca Pharmaceuticals LP |
| LABELER NAME: | AstraZeneca Pharmaceuticals LP |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 50(mg/mL) |
| START MARKETING DATE: | 2010-11-01 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0310-0720_d1a88435-fae6-49b8-81a0-e6d6f22a568c |
| PRODUCT NDC: | 0310-0720 |
| APPLICATION NUMBER: | NDA021344 |
Other FULVESTRANT Pharmaceutical Manufacturers / Labelers:
